8 results about "Cannabinol" patented technology

The present invention generally relates to methods for producing (a) plant extract(s), preferably a Cannabis plant extract. In particular, the present invention relates to a method for producing a Cannabis plant extract comprising delta-9-tetrahydrocannabinol (THC) from a Cannabis plant comprising the following steps: (a) providing a Cannabis plant which comprises delta-9-tetrahydrocannabinol (THC) in a sufficient amount: (b) trimming and drying the flower material separated from the remaining plant material; and (c) treating the flower material of step (b) with a solvent and separating the Cannabis plant extract comprising delta-9-tetrahydrocannabinol (THC) from the flower material. Furthermore, the invention relates to a Cannabis plant extract comprising delta-9-tetrahydrocannabinol (THC) as produced by / obtainable by the methods described herein. Furthermore, the invention relates to the Cannabis plant extract as produced by / obtainable by the herein described methods for use in medicine. Moreover, the present invention relates to the Cannabis plant extract as produced by / obtainable by the herein described methods for use in the treatment and / or prevention of chronic cancer pain, somatic pain, visceral pain, central neuropathic pain, peripheral neuropathic pain and complex pain syndromes.

The present disclosure relates to polymorphs of D9-THC-naphthoylester for the preparation of D9-Tetrahydrocannabinol in high yields and high purity, methods of preparing the D9-Tetrahydrocannabinol, and compositions comprising the D9-Tetrahydrocannabinol.

Decarboxylated cannabis compositions and methods of making and using the same are provided. The methods produce a decarboxylated product that has more terpenes and cannabidiol preserved and less oxidation of tetrahydrocannabinol to cannabinol, compared to a decarboxylated product made by a traditional decarboxylation process.

In one aspect, the disclosure relates to substituted axially-chiral cannabinol analogs, methods of making same, pharmaceutical compositions comprising same, and methods of treating pain using same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

The present invention relates to a modified-release solid oral pharmaceutical composition, which is in the form of an enteric-coated capsule, wherein said capsule comprises cannabidiol (CBD), tetrahydrocannabinol (THC) and an emulsifier, and wherein the capsule optionally further comprises one or more cannabis terpenes. The solid oral pharmaceutical composition provided herein has a particularly advantageous modified release profile as well as an improved oral bioavailability as compared to conventional formulations of CBD and THC.

The invention relates to a method for destroying tetrahydrocannabinol (THC), in particular to a method and a system for destroying tetrahydrocannabinol based on photocatalytic oxidation. According to the invention, nano titanium dioxide (TiO2) is used as a catalyst, active oxygen free radicals are generated under the excitation of ultraviolet rays with specific wavelength, and the THC molecular structure is decomposed. The multi-stage reaction system is adopted, raw material pretreatment, solvent dissolution and dispersion, photocatalytic degradation reaction and tail gas purification modules are integrated, tetrahydrocannabinol is decomposed on a production line, the supervision pressure in production is relieved, the degradation rate of tetrahydrocannabinol reaches 99% or above, degradation products are carbon dioxide, water and trace inert organic acid, and high efficiency and environment friendliness are achieved. The method is suitable for innocent treatment of hemp processing waste, law enforcement inspection products or medical waste, and is simple to operate, high in practicability and suitable for industrial popularization and application.

In one aspect, the disclosure relates to substituted axially-chiral cannabinol analogs, methods of making same, pharmaceutical compositions comprising same, and methods of treating pain using same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

The invention discloses a preparation and quantitative analysis method of a 9-tetrahydrocannabinol cis-trans isomer. The invention provides a preparation method of (+ / -)-9-trans-THC or (+ / -)-9-cis-THC. The preparation method comprises the following steps: separating a mixture of (+ / -)-9-trans-THC and (+ / -)-9-cis-THC by adopting chromatography; the separation conditions of the chromatography are as follows: a chromatographic column is a C18 chromatographic column; the mobile phase is acetonitrile and water; the volume ratio of the acetonitrile to the water is (7: 3)-(3: 1). The (+ / -)-9-trans-THC and (+ / -)-9-cis-THC prepared by the method disclosed by the invention are high in purity, and the quantitative analysis method provided by the invention realizes accurate quantification under the condition of no standard reference substance, and also has the advantages of no damage to samples, simple preparation, high analysis speed, good accuracy, good repeatability and the like.